Lilly cuts prices on Zepbound vials sold on LillyDirect
The decision is the latest in a series of moves to make its GLP-1 blockbuster more widely available and affordable.
Health Care
Articles
IU Health prepares for huge increase in energy use with $4.3B hospital complex
The health care system’s plan to meet its energy needs includes working closely with its electricity provider, AES Indiana, building additional backup power systems and operating its own natural gas utility plant for heating and cooling.
Lilly rolling out direct-to-employer obesity drug coverage
The Indianapolis-based drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers.
Indiana unveils multiyear rural health plan in newly released federal application
The plan is described as a “collaborative effort” to be jointly led by the Indiana Family and Social Services Administration and the Indiana Department of Health.
Indiana cigarette consumption down, cessation program enrollment up after tax hike
The boost to a nearly $3-a-pack tax on cigarettes went into effect July 1 is already bringing in significantly more tax revenue.
Encompass Health to build rehabilitation hospital in Fishers
The facility will be the third in Indiana for Encompass Health Corp., the nation’s largest owner and operator of inpatient rehabilitation hospitals.
Lilly to open Gateway Labs site in Philadelphia
Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.
Roche survey: Many millennial women skipping cervical cancer screenings
Indianapolis-based Roche Diagnostics said while the survey was conducted in Europe, its implications are global and reflect challenges in the United States.
Orthopedic surgeon takes blunt approach to reforming care
Dr. Michael Meneghini waited out a two-year noncompete clause after leaving Indiana University Health before opening the $35 million Indiana Orthopedic Institute early this year.
Franciscan Health to build $60M, 40-bed rehab hospital on south Indy campus
The new facility will include larger patient rooms, advanced therapy gyms and devices such as advanced technology walking aids to help people regain mobility after major injury.
Lilly CEO calls on state to boost power supply as company seeks to build supercomputer
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
New Indianapolis venture studio aims to launch 8-12 startups in next few years
Indianapolis-based Alloy Partners says its OneHealth Studio, a venture studio that quietly began operating last month in partnership with Elanco Animal Health Inc., will be ready to create its first startups early next year.
Purdue heads clinical trial for new canine cancer treatment
Researchers say the new treatment holds the potential to treat some dogs diagnosed with cancer without turning to more expensive traditional procedures such as radiation, chemotherapy or surgery.
Financially struggling Riverview Health formalizes services agreement with Parkview Health
The strategic consulting agreement with the Fort Wayne-based hospital system comes as the Hamilton County-owned Riverview is recovering from consecutive years of operating losses.
Lilly’s obesity pill, orforglipron, gets FDA fast-track voucher
The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce costs for patients on government-funded insurance and those paying out of pocket.
IU Health taps OrthoIndy leader for top strategy role
During John Ryan’s tenure as CEO of OrthIndy, the practice expanded its services and footprint both locally and across Indiana.
Elanco’s Q3 earnings top Wall Street forecasts as company continues to deal with debt
Despite reporting a loss, the company saw quarterly growth in the double digits and raised its full-year earnings estimate.
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7B consumer brands deal
The combined consumer health goods company is expected to generate about $32 billion in annual revenue.
Eli Lilly to build $3B manufacturing site in Netherlands
The facility is expected to produce oral medications, including Lilly’s highly anticipated GLP-1 pill for weight loss, orforglipron.
Lilly earnings soar on growth of Mounjaro, Zepbound
With quarterly revenue up 54% from a year ago, Eli Lilly raised it guidance for the year, with the company now expecting revenue in the range of $63 billion to $63.5 billion.